{"id":"https://openalex.org/W1962555352","doi":"https://doi.org/10.1111/j.1365-2885.2010.01183.x","title":"Population pharmacokinetics of mavacoxib in osteoarthritic dogs","display_name":"Population pharmacokinetics of mavacoxib in osteoarthritic dogs","alternate_titles":[],"publication_year":2010,"publication_date":"2010-06-18","ids":{"openalex":"https://openalex.org/W1962555352","doi":"https://doi.org/10.1111/j.1365-2885.2010.01183.x","mag":"1962555352","pmid":"https://pubmed.ncbi.nlm.nih.gov/21219337"},"language":"en","primary_location":{"id":"doi:10.1111/j.1365-2885.2010.01183.x","doi":"https://doi.org/10.1111/j.1365-2885.2010.01183.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1365-2885.2010.01183.x","pdf_url":null,"source":{"id":"https://openalex.org/S23625584","display_name":"Journal of Veterinary Pharmacology and Therapeutics","issn_l":"0140-7783","issn":["0140-7783","1365-2885"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","jufo-2","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Veterinary Pharmacology and Therapeutics","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1962555352"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5113661686","display_name":"Steven R. Cox","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"S. R. COX","raw_affiliation_strings":["Veterinary Medicine Research and Development, Pfizer Inc., Kalamazoo, MI MI 49001-0199,, USA. steven.r.cox@pfizer.com","Veterinary Medicine Research and Development, Pfizer Inc., Kalamazoo, MI, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Veterinary Medicine Research and Development, Pfizer Inc., Kalamazoo, MI MI 49001-0199,, USA. steven.r.cox@pfizer.com","institution_ids":["https://openalex.org/I180857899"]},{"raw_affiliation_string":"Veterinary Medicine Research and Development, Pfizer Inc., Kalamazoo, MI, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054149626","display_name":"Sam Liao","orcid":"https://orcid.org/0000-0002-2710-7890","observed_orcids":["https://orcid.org/0000-0002-2710-7890"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S. LIAO","raw_affiliation_strings":["Pharmax Research Inc., Somerset, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmax Research Inc., Somerset, NJ, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016293005","display_name":"Mark Payne-Johnson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. PAYNE\u2010JOHNSON","raw_affiliation_strings":["Veterinary Medicine Research and Development, Pfizer Inc., Kalamazoo, MI, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Veterinary Medicine Research and Development, Pfizer Inc., Kalamazoo, MI, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021568848","display_name":"R. J. ZIELINSKI","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"R. J. ZIELINSKI","raw_affiliation_strings":["Veterinary Medicine Research and Development, Pfizer Inc., Kalamazoo, MI, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Veterinary Medicine Research and Development, Pfizer Inc., Kalamazoo, MI, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5056887296","display_name":"Michael R. Stegemann","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I189718659","display_name":"Pfizer (United Kingdom)","ror":"https://ror.org/04x4v8p40","country_code":"GB","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I189718659"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"M. R. STEGEMANN","raw_affiliation_strings":["Pfizer Inc., Sandwich, Kent, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Inc., Sandwich, Kent, UK","institution_ids":["https://openalex.org/I189718659"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5113661686"],"corresponding_institution_ids":["https://openalex.org/I180857899"],"apc_list":{"value":4520,"currency":"USD","value_usd":4520},"apc_paid":null,"fwci":6.3877,"has_fulltext":false,"cited_by_count":54,"citation_normalized_percentile":{"value":0.96898691,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":99},"biblio":{"volume":"34","issue":"1","first_page":"1","last_page":"11"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11905","display_name":"Veterinary Pharmacology and Anesthesia","score":0.8809000253677368,"subfield":{"id":"https://openalex.org/subfields/3404","display_name":"Small Animals"},"field":{"id":"https://openalex.org/fields/34","display_name":"Veterinary"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11905","display_name":"Veterinary Pharmacology and Anesthesia","score":0.8809000253677368,"subfield":{"id":"https://openalex.org/subfields/3404","display_name":"Small Animals"},"field":{"id":"https://openalex.org/fields/34","display_name":"Veterinary"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.0828000009059906,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11580","display_name":"Veterinary Medicine and Surgery","score":0.01269999984651804,"subfield":{"id":"https://openalex.org/subfields/3404","display_name":"Small Animals"},"field":{"id":"https://openalex.org/fields/34","display_name":"Veterinary"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/population-pharmacokinetics","display_name":"population pharmacokinetics","score":0.8399999737739563},{"id":"https://openalex.org/keywords/canine-osteoarthritis","display_name":"canine osteoarthritis","score":0.8679999709129333},{"id":"https://openalex.org/keywords/cox-2-inhibitors","display_name":"COX-2 inhibitors","score":0.8379999995231628},{"id":"https://openalex.org/keywords/dogs","display_name":"dogs","score":0.6909999847412109},{"id":"https://openalex.org/keywords/oral-clearance","display_name":"oral clearance","score":0.6230000257492065},{"id":"https://openalex.org/keywords/volume-of-distribution","display_name":"volume of distribution","score":0.996999979019165},{"id":"https://openalex.org/keywords/between-subject-variability","display_name":"between-subject variability","score":0.9240000247955322},{"id":"https://openalex.org/keywords/breed-effects","display_name":"breed effects","score":0.5979999899864197},{"id":"https://openalex.org/keywords/bioavailability","display_name":"bioavailability","score":0.7860000133514404},{"id":"https://openalex.org/keywords/elimination-half-life","display_name":"elimination half-life","score":0.7379999756813049},{"id":"https://openalex.org/keywords/dose-reduction","display_name":"dose reduction","score":0.7699999809265137},{"id":"https://openalex.org/keywords/therapeutic-index","display_name":"therapeutic index","score":0.652999997138977},{"id":"https://openalex.org/keywords/one-compartment-model","display_name":"one-compartment model","score":0.6019999980926514}],"concepts":[{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.7225325703620911},{"id":"https://openalex.org/C181389837","wikidata":"https://www.wikidata.org/wiki/Q461809","display_name":"Bioavailability","level":2,"score":0.6872978210449219},{"id":"https://openalex.org/C139254425","wikidata":"https://www.wikidata.org/wiki/Q1332167","display_name":"Volume of distribution","level":3,"score":0.6198870539665222},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.5735421776771545},{"id":"https://openalex.org/C162156334","wikidata":"https://www.wikidata.org/wiki/Q473420","display_name":"Dose","level":2,"score":0.5735309720039368},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4946121871471405},{"id":"https://openalex.org/C2776164576","wikidata":"https://www.wikidata.org/wiki/Q62736","display_name":"Osteoarthritis","level":3,"score":0.48232007026672363},{"id":"https://openalex.org/C2776482104","wikidata":"https://www.wikidata.org/wiki/Q38829","display_name":"Breed","level":2,"score":0.4122586250305176},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3895655870437622},{"id":"https://openalex.org/C140793950","wikidata":"https://www.wikidata.org/wiki/Q168091","display_name":"Animal science","level":1,"score":0.3591705560684204},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3082362115383148},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.10250753164291382},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.06850335001945496},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000096926","descriptor_name":"Benzenesulfonamides","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000894","descriptor_name":"Anti-Inflammatory Agents, Non-Steroidal","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000894","descriptor_name":"Anti-Inflammatory Agents, Non-Steroidal","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D000894","descriptor_name":"Anti-Inflammatory Agents, Non-Steroidal","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D000894","descriptor_name":"Anti-Inflammatory Agents, Non-Steroidal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001835","descriptor_name":"Body Weight","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004283","descriptor_name":"Dog Diseases","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004285","descriptor_name":"Dogs","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006207","descriptor_name":"Half-Life","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008954","descriptor_name":"Models, Biological","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010003","descriptor_name":"Osteoarthritis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D010003","descriptor_name":"Osteoarthritis","qualifier_ui":"Q000662","qualifier_name":"veterinary","is_major_topic":true},{"descriptor_ui":"D011720","descriptor_name":"Pyrazoles","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D011720","descriptor_name":"Pyrazoles","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D011720","descriptor_name":"Pyrazoles","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D011720","descriptor_name":"Pyrazoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1111/j.1365-2885.2010.01183.x","doi":"https://doi.org/10.1111/j.1365-2885.2010.01183.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1365-2885.2010.01183.x","pdf_url":null,"source":{"id":"https://openalex.org/S23625584","display_name":"Journal of Veterinary Pharmacology and Therapeutics","issn_l":"0140-7783","issn":["0140-7783","1365-2885"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","jufo-2","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Veterinary Pharmacology and Therapeutics","raw_type":"journal-article"},{"id":"pmid:21219337","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21219337","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of veterinary pharmacology and therapeutics","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9476000070571899}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":14,"referenced_works":["https://openalex.org/W1513076951","https://openalex.org/W1984189311","https://openalex.org/W1994202365","https://openalex.org/W2039796430","https://openalex.org/W2054565825","https://openalex.org/W2063057668","https://openalex.org/W2083668821","https://openalex.org/W2120416054","https://openalex.org/W2121850944","https://openalex.org/W2131764590","https://openalex.org/W2159543650","https://openalex.org/W2159562550","https://openalex.org/W2161446377","https://openalex.org/W2969224515"],"related_works":["https://openalex.org/W1988905992","https://openalex.org/W2121850944","https://openalex.org/W4244284669","https://openalex.org/W268434392","https://openalex.org/W2022022427","https://openalex.org/W2966495548","https://openalex.org/W4361298483","https://openalex.org/W4414471465","https://openalex.org/W2754402576","https://openalex.org/W2055098850"],"abstract_inverted_index":{"Mavacoxib":[0,43,209],"(Trocoxil\u2122)":[1],"is":[2,188],"an":[3],"oral":[4,83],"long-acting":[5],"COX-2":[6],"inhibitor":[7],"approved":[8],"for":[9,82,185,196,231,304],"the":[10,61,71,103,107,114,117,192,198,260,264,284,291,301],"treatment":[11],"of":[12,29,88,109,120,125,142,157,221,223,245,253,266,283],"osteoarthritis":[13],"in":[14,21,102,197,206,214],"dogs.":[15],"Two":[16],"field":[17,170],"trials":[18],"were":[19,46,97,100,135],"conducted":[20],"client-owned":[22],"dogs":[23],"suffering":[24],"from":[25,48,53,77,146,293],"osteoarthritis,":[26],"with":[27,149,176,219,259,269,280],"dosages":[28],"4":[30,294],"mg/kg":[31,39,272,297],"body":[32],"weight":[33],"(BW)":[34],"(Study":[35,41],"1)":[36],"or":[37],"2":[38,271,296],"BW":[40],"2).":[42],"plasma":[44,235,276],"concentrations":[45,278],"determined":[47],"trough":[49,275],"blood":[50,54],"samples":[51,55],"and":[52,80,92,128,132,152,180,216,225,298],"collected":[56],"at":[57],"4-10":[58],"months":[59],"after":[60],"last":[62],"dose.":[63],"A":[64],"one-compartment":[65],"linear":[66],"model":[67,104,200,261],"was":[68,122,160,194,239],"fitted":[69],"to":[70,137,162,173,178,289,295],"concentration":[72,75],"data":[73],"(1317":[74],"records":[76],"286":[78],"patients),":[79],"parameters":[81],"clearance":[84],"(Cl/F),":[85],"apparent":[86],"volume":[87],"distribution":[89],"(V(d)":[90],"/F)":[91],"their":[93],"between-subject":[94],"variabilities":[95],"(BSV)":[96],"estimated.":[98],"Covariates":[99],"included":[101],"based":[105],"on":[106,166],"outcomes":[108],"stepwise":[110],"regression":[111],"procedures.":[112],"In":[113],"final":[115,199],"model,":[116],"typical":[118,155,229],"value":[119,156,230],"Cl/F":[121,143,179,215],"a":[123,202,243],"function":[124],"BW,":[126],"age":[127],"breed.":[129],"German":[130],"shepherds":[131],"Labrador":[133],"retrievers":[134],"found":[136,161],"have":[138],"31%":[139],"higher":[140],"values":[141],"than":[144],"patients":[145,246,267],"different":[147],"breeds":[148],"similar":[150],"ages":[151],"BWs.":[153],"The":[154,168,183,228],"V(d)":[158,181,217],"/F":[159],"be":[163],"dependent":[164],"only":[165],"BW.":[167],"two":[169],"studies":[171],"appeared":[172],"differ":[174],"similarly":[175],"respect":[177],"/F.":[182],"explanation":[184],"this":[186,305],"difference":[187,193],"not":[189],"known,":[190],"but":[191,242],"accounted":[195],"as":[201],"23.9%":[203],"lower":[204],"bioavailability":[205],"Study":[207],"2.":[208],"exhibited":[210],"relatively":[211],"broad":[212],"BSV":[213],"/F,":[218],"coefficients":[220],"variation":[222],"47%":[224],"19%,":[226],"respectively.":[227],"mavacoxib's":[232],"terminal":[233],"elimination":[234],"half-life":[236],"(t(1/2)":[237],")":[238],"44":[240],"days,":[241],"minority":[244],"(approximately":[247],"5%)":[248],"had":[249],"empirical":[250],"Bayes":[251],"estimates":[252],"t(1/2)":[254],"exceeding":[255],"80":[256],"days.":[257],"Simulations":[258],"indicated":[262],"that":[263],"majority":[265],"treated":[268],"mavacoxib":[270,277],"will":[273],"maintain":[274],"associated":[279],"efficacy.":[281],"Results":[282],"population":[285],"pharmacokinetic":[286],"analysis":[287],"helped":[288],"reduce":[290],"dose":[292],"thus":[299],"increased":[300],"therapeutic":[302],"index":[303],"molecule.":[306]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1962555352","counts_by_year":[{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":4},{"year":2015,"cited_by_count":6},{"year":2014,"cited_by_count":7},{"year":2013,"cited_by_count":8},{"year":2012,"cited_by_count":4}],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2016-06-24T00:00:00"}
